Drug-Induced Autoimmune Hepatitis From Hydralazine Leading to Acute Liver Failure and Liver Transplantation
Authors:
Open Access
- 1 October 2019
- journal article
- research article
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 6 (10) , e00252
Abstract
We describe a woman with no previous liver disease who developed drug-induced autoimmune hepatitis from hydralazine prescribed to her for hypertension. Despite the discontinuation of the medication, she developed acute liver failure and subsequently underwent successful liver transplantation. She survived and had a good clinical outcome.Keywords
This publication has 11 references indexed in Scilit:
- “Autoimmune(-Like)” Drug and Herb Induced Liver Injury: New Insights into Molecular PathogenesisInternational Journal of Molecular Sciences, 2017
- The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injuryHepatology, 2011
- Diagnosis and Management of Autoimmune HepatitisHepatology, 2010
- Hydralazine-Induced Cholestatic HepatitisAmerican Journal of Therapeutics, 2009
- Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United StatesAnnals of Internal Medicine, 2002
- Epidemiology and Individual Susceptibility to Adverse Drug Reactions Affecting the LiverSeminars in Liver Disease, 2002
- Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative)Hepatology, 1996
- Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative)Hepatology, 1996
- Early indicators of prognosis in fulminant hepatic failureGastroenterology, 1989
- Hydralazine-Induced CholangitisGastroenterology, 1984